brokerbase

About tradingpattern.net

The movement of a security's price over a specific time period.

dedicated to value creation and applying the scientific method in finance

Search


www.brokerbase.ch network - market statistics - weekly update

www.brokerbase.ch High dividend yield stocks

www.brokerbase.ch network

3M Activision Blizzard Adobe Systems Affimetrix Airlines Akamai Tech Alcoa Altera Amazon.com American Express American Tower Amgen Amylin Pharma Analyst Rating AngloGold Apollo Group Apple Applied Materials AT&T Autodesk Automatic Data Processing Baidu Bank of America Baxter Bed Bath & Beyond Blackrock Boeing Broadcom C.H. Robinson CA Caterpillar Celgene Cephalon Charts Check Point Software Chevron Cintas Corporation Cisco Systems Citigroup Citrix Coca Cola Cognizant Comcast Costco Wholesale Cree Dell DENTSPLY DIRECTV Discount, Variety Stores DISH Disney Dow 30 Downgrade Dr. Reddy's Laboratories Du Pont eBay Electronic Arts EMC Corporation Expedia Express Scripts Extreme Networks Exxon Mobil FANNIE MAE Fastenal First Solar Fiserv Flextronics FLIR Ford Foster Wheeler FREDDIE MAC Freeport-McMoRan Garmin Genentech General Electric Genzyme Gilead Sciences Golden Star Resources Goldman Sachs Google Hansen Natural Hardware Healthcare Hecla Mining Henry Schein Hewlett Packard Hologic Home Depot Human Genome Science IBM Illumina Industry Infosys Initial Recommendation Intel InterActive Corp Intuit Intuitive Surgical Johnson & Johnson Joy Global JP Morgan Juniper Networks KKR KLA-Tencor Kraft Foods Lam Research Level 3 Liberty Global Liberty Media Life Technologies Linear Technology Lockheed Martin Logitech Marvell Technology MasterCard Maxim Integrated McDonalds Merck Merril Lynch Microchip Technology Microsoft Millicom Morgan Stanley Nasdaq 100 NetApp NETFLIX Network Network Appliance Newmont Mining News Corporation NII Holdings Noble NVIDIA O'Reilly Automotive Occidental Petroleum Oracle PACCAR Patterson Paychex Petrohawk PETROLEO BRASILEIRO Pfizer Procter & Gamble Qualcomm Quanta Renhe Commercial Holdings Research in Motion Riverbed Technology Ross Stores Royal Gold Ryanair S&P 500 salesforce.com SanDisk Seagate Sears Holdings Semiconductor - Integrated Circuits Services Sigma-Aldrich Software Southwest Airlines Staples Starbucks Steel & Iron Steel Dynamics Stericycle Symantec Synaptics Technology Teva Texas Instruments Ticker Travelers Uncategorized United Continental Holdings United Technologies Upgrade Urban Outfitters VeriSign Verizon Vertex Pharmaceuticals Visa Wal Mart Warner Chilcott Wells Fargo Wynn Resorts Xilinx XTO Yahoo Zoltek

www.brokerbase.ch network - archived market statistics

Blogroll

Recent Posts

Illumina

« Previous Entries

Roche gibt angediente Illumina-Aktien zurueck

Monday, April 23rd, 2012

Roche will Angebot fuer Illumina nicht verlaengern

Wednesday, April 18th, 2012

Roche sieht keinen Grund fuer hoehere Illumina-Offerte

Thursday, April 12th, 2012

WSJ – Illumina lehnt auch hoehere Offerte von Roche ab

Tuesday, April 3rd, 2012

Roche-Uebernahmeziel Illumina setzt mehr um als erwartet

Monday, April 2nd, 2012

Roche erhoeht Illumina-Angebot auf 51 USD je Aktie

Thursday, March 29th, 2012

Roche dehnt Angebotsperiode fuer Illumina erneut aus

Monday, March 26th, 2012

Roche wendet sich bei Illumina-Uebernahme direkt an die Aktionaere

Tuesday, March 20th, 2012

Illumina neutral – New Analyst Rating from UBS AG

Wednesday, February 29th, 2012

Illumina neutral – New Analyst Rating from UBS AG

Tuesday, February 28th, 2012

Roche verlaengert Uebernahmeangebot fuer Illumina

Monday, February 27th, 2012

Illumina sector perform – New Analyst Rating from RBC Capital Markets

Thursday, February 9th, 2012

Illumina wehrt sich weiter gegen Uebernahme von Roche

Wednesday, February 8th, 2012

Illumina neutral – New Analyst Rating from UBS AG

Friday, January 27th, 2012

Roche-Uebernahmeziel Illumina wehrt sich

Friday, January 27th, 2012

Illumina outperform – New Analyst Rating from Robert W. Baird & Co. Incorporated

Thursday, January 26th, 2012

Illumina (ILMN) Upgrade from Neutral to Outperform – Analyst rating from Robert W. Baird

Wednesday, January 25th, 2012

Illumina outperform – New Analyst Rating from Robert W. Baird & Co. Incorporated

Wednesday, January 25th, 2012

Illumina ( ILMN ) Upgrade from Neutral to Outperform($60) – Analyst rating from Robert W. Baird

Wednesday, January 25th, 2012

Illumina neutral – New Analyst Rating from UBS AG

Monday, October 10th, 2011

Illumina hold – New Analyst Rating from Deutsche Bank Securities

Monday, October 10th, 2011

Illumina ( ILMN ) Downgrade from Buy to Neutral($32) – Analyst rating from UBS

Friday, October 7th, 2011

Illumina (ILMN) Downgrade from Buy to Hold – Analyst rating from Maxim Group

Friday, October 7th, 2011

Illumina ( ILMN ) Downgrade from Buy to Hold – Analyst rating from Maxim Group

Friday, October 7th, 2011

ILMN – Illumina Announces New $100 Million Share Repurchase Authorization

Wednesday, August 3rd, 2011

Illumina Shares Plunged

Wednesday, July 27th, 2011

The San Diego company raised its profit and revenue outlook on Tuesday after reporting its second-quarter results. Illumina now says its adjusted profit will grow 33 to 36 percent from 2010 and revenue 24 to 26 percent. In February, it said its profit would grow at least 30 percent while revenue would rise about 20 [...]

Illumina 2nd-quarter earnings beat views.

Wednesday, July 27th, 2011

Genetic analysis instrument maker Illumina Inc. said Tuesday that its second-quarter net income edged higher as revenue grew by a third. It raised its annual profit and revenue forecast but the new outlook still came below what analysts were expecting. Net income in the three months through July 3 rose to $30.6 million, or 22 [...]

ILMN – Illumina to Present at Leerink Swann Life Science Tools and Diagnostics Roundtable

Wednesday, July 27th, 2011

ILMN – Illumina Reports Financial Results for Second Quarter 2011

Tuesday, July 26th, 2011

ILMN – Illumina Announces First Customer Shipments of the Omni5 BeadChip

Monday, July 25th, 2011

ILMN – Illumina Selected as a Preferred Service Provider for Cancer Research UK

Thursday, July 14th, 2011

ILMN – Illumina Introduces TruSeq(TM) Custom Enrichment Kits for Next Generation Sequencing

Wednesday, July 13th, 2011

ILMN – Illumina to Announce Second Quarter 2011 Financial Results on Tuesday, July 26, 2011

Tuesday, July 12th, 2011

ILMN – Sequenom Announces Multi-Year Supply Agreement With Illumina

Monday, July 11th, 2011

ILMN – University of Washington Department of Genome Sciences Joins Illumina Genome Network

Wednesday, June 29th, 2011

Illumina ( ILMN ) Initial Recommendation Buy – Analyst rating from Maxim Group

Tuesday, June 21st, 2011

Illumina (ILMN) Initial Recommendation – Buy – Analyst rating from Maxim Group

Tuesday, June 21st, 2011

ILMN – Insider Trading Alerts for CVS, Tiffany, Illumina, Dolby, Texas Industries, & Helix

Tuesday, June 21st, 2011

ILMN – Illumina to Webcast Live Presentations at Upcoming Investment Conferences in June

Wednesday, June 1st, 2011

Illumina overweight – New Analyst Rating from Morgan Stanley

Monday, May 16th, 2011

ILMN – GenoLogics Launches LIMS Pre-Configured for Illumina Next-Gen Sequencing Systems and Sample Prep Kits

Tuesday, May 10th, 2011

ILMN – Illumina Reduces Price of Whole Human Genome Sequencing Through Illumina Genome Network

Monday, May 9th, 2011

ILMN – Illumina Reports Financial Results for First Quarter 2011

Tuesday, April 26th, 2011

ILMN – Illumina to Present at Upcoming Investment Conferences in May

Tuesday, April 26th, 2011

ILMN – Illumina to Announce First Quarter 2011 Financial Results on Tuesday, April 26, 2011

Tuesday, April 12th, 2011 « Previous Entries